Pfizer pulls blood pressure medicines in US over cancer-causing impurities

Earlier this month, Pfizer kicked off two recalls in Canada for two of its blood pressure medicines. Now the company is pulling three of its blood pressure drugs off shelves in the United States because of the presence of cancer-causing agents.

On Monday, Pfizer issued a voluntary recall of its blood pressure drug Accuretic along with a pair of its generic hypertension treatments distributed by Greenstone.